Shanghai, China
Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Caproasia - Learn more



This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $30 billion.











China Clinical-Stage Biotech Company HJ Science Hong Kong IPO to Raise $130 Million at $768 Million Valuation with Expected IPO Listing on 23rd June 2026, Founded in 2017 by Ji Jianxin

13th June 2026 | Hong Kong

China clinical-stage biotech company HJ Science Hong Kong IPO is raising $130 million at $768 million valuation, with expected IPO listing on 23rd June 2026.  HJ Science was founded in 2017 by Ji Jianxin. HJ Science – We are a clinical-stage biotech company founded by a team of industrial experts in 2017, dedicated to researching and developing therapies for autoimmune, metabolic and oncology diseases. We have three Core Products—HJ787, HJ178 and HJ891—all of which are self-developed, small-molecule NMPA Category 1 innovative drugs. HJ787 is a selective TYK2 inhibitor intended for the topical treatment of mild-to-moderate atopic dermatitis (AD), mild-to-moderate acne vulgaris (AV), neurodermatitis (ND) and psoriasis (Ps) and the oral treatment of AD, ND and Ps in the autoimmune sector. HJ178 is an orally available agent acting on GLP-1 and GIP, intended for type 2 diabetes and potentially overweight or obesity in the metabolic sector. HJ891 is an oral KRASG12C inhibitor intended for the treatment of non-small-cell lung cancer (NSCLC) with KRASG12C mutation that has progressed following first-line standard therapies as monotherapy and non-squamous NSCLC with KRASG12C mutation as first-line combination therapy, in the oncology sector. As of the Latest Practicable Date, we also had one clinical-stage drug candidate HJ197 and five preclinical drug candidates—HJ356, HJ093, HJ199, HJ198 and HJ086—all of which are also self-developed, small-molecule NMPA Category 1 innovative therapies.

“ China Clinical-Stage Biotech Company HJ Science Hong Kong IPO to Raise $130 Million at $768 Million Valuation with Expected IPO Listing on 23rd June 2026, Founded in 2017 by Ji Jianxin “

 



- Article continues below -



Intelligence at your fingertips
Get Started ($29 per year) : Click here
Caproasia Subscription ($680 yearly | $70 monthly): Click here


The 2026 Investment Day
Hong Kong | Singapore
March / July / Sept / Oct / Nov

Private Equity, Hedge Funds, Boutique Funds, Private Markets & more. Join 20+ CIOs & Senior investment team, with > 60% single family offices with $300 million AUM. Taking place in Hong Kong and in Singapore. Every March, April, July, Sept, Oct & Nov.
Visit | Register here


The 2026 Family Office Summit
9th / 16th April & 15th Oct Hong Kong Ritz Carlton | 23rd / 30th April & 5th Nov Singapore Amara Sanctuary Resort

Join 60 single family offices & family office professionals in Hong Kong & Singapore
Links: 2026 Family Office Summit | Register here


2026 Investment / Alternatives Summit
March / Oct / Nov in Hong Kong & Singapore

Join leading asset managers, hedge funds, boutique funds, private equity, venture capital & real estate firms in Hong Kong, Singapore & Asia-Pacific at the Investment / Alternatives Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here


2026 Private Wealth Summit
April / Oct / Nov in Hong Kong & Singapore

Join CEOs, CIOs, Head of Private Banking, Head of Family Offices & Product Heads at The Private Wealth Summit.  Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here





 

China Clinical-Stage Biotech Company HJ Science Hong Kong IPO to Raise $130 Million at $768 Million Valuation with Expected IPO Listing on 23rd June 2026, Founded in 2017 by Ji Jianxin

Shanghai, China



Managing $20 million to $3 billion. Investing $3 million to $300 million.
For Investment Managers, Hedge Funds, Boutique Funds, Private Equity, Venture Capital, Professional Investors, Family Offices, Private Bankers & Advisors, sign up today. Subscribe to Caproasia and receive the latest news, data, insights & reports, events & programs daily at 2 pm.

Join Events & Find Services
Join Investments, Private Wealth, Family Office events in Hong Kong, Singapore, Asia-wide. Find hard-to-find $3 million to $300 million financial & investment services at The Financial Centre | TFC. Find financial, investment, private wealth, family office, real estate, luxury investments, citizenship, law firms & more.  List hard-to-find financial & private wealth services.

Have a product launch? Promote a product or service? List your service at The Financial Centre | TFC. Join interviews & editorial and be featured on Caproasia.com or join Investments, Private Wealth, Family Office events. Contact us at [email protected] or [email protected]

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets?



Quick Links



Web links may be disabled on mobile for security.
Please click on desktop.










Caproasia Users

  • Manage $20 million to $30 billion of assets
  • Invest $3 million to $300 million
  • Advise institutions, billionaires, UHNWs & HNWs

Caproasia Platforms | 11,000 Investors & Advisors

Monthly Roundtable & Networking

Family Office Programs

The 2026 Investment Day

  • March - Hong Kong
  • March - Singapore
  • April - Hong Kong
  • April - Singapore
  • July - Hong Kong
  • July - Singapore
  • Sept- Hong Kong
  • Sept - Singapore
  • Oct- Hong Kong
  • Nov - Singapore
  • Visit: The Investment Day | Register: Click here

Caproasia Summits

Contact Us

For Enquiries, Membership
[email protected], [email protected]

For Listing, Subscription
[email protected], [email protected]

For Press Release, send to:
[email protected]

For Events & Webinars
[email protected]

For Media Kit, Advertising, Sponsorships, Partnerships
[email protected]

For Research, Data, Surveys, Reports
[email protected]

For General Enquiries
[email protected]





Caproasia | Driving the future of Asia
a financial information technology co.
since 2014